[BiO BB] New Targets and Drug Modalities

James Prudhomme jprudhomme at healthtech.com
Wed Apr 20 12:06:14 EDT 2011

CHI and Bio-IT World's "Structure-Based Design" Conference to be 
held on June 8-10, 2011 in Cambridge, MA, will feature a new session:  
New Targets and Drug Modalities.

The following presentations have just been added and are scheduled 
on Friday, June 10 from 1:30-3:50 p.m.

Structure-Based Ligand Discovery for GPCRs Ruben Abagyan, Ph.D., 
Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, 
University of California, San Diego

The Role of Recent Crystal Structures of Membrane Bound Proteins in 
Drug Discovery for CNS Targets Sid Topiol, Ph.D., CSO, Computational 
and Structural Investigations, 3D-2Drug

Hitting a Moving Target: Characterizing GPCR Signaling through Long-
timescale Molecular Dynamics Simulations Ron Dror, Ph.D., Senior 
Research Scientist and Special Advisor to the Chairman, D. E. Shaw 

Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of 
the D3R Selective Compounds Lei Shi, Ph.D., Assistant Professor, 
Department of Physiology and Biophysics, HRH Prince Alwaleed Bin 
Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, 
Weill Cornell Medical College

Moving in New Circles - Exploiting Macrocycles for Drug Discovery Nick 
Terrett, Ph.D., CSO, Ensemble Therapeutics Corp

View full details and register at: http://www.healthtech.com/sbd or call 

Those that register by April 29 will receive the advanced registration 

- James Prudhomme

James Prudhomme
Marketing Manager
Cambridge Healthtech Institute
Tel: 781-972-5486
jprudhomme at healthtech.com

More information about the BBB mailing list